Cargando…
Advances in proton therapy in lung cancer
Lung cancer remains the leading cause of cancer deaths in the United States (US) and worldwide. Radiation therapy is a mainstay in the treatment of locally advanced non-small cell lung cancer (NSCLC) and serves as an excellent alternative for early stage patients who are medically inoperable or who...
Autores principales: | Vyfhuis, Melissa A.L., Onyeuku, Nasarachi, Diwanji, Tejan, Mossahebi, Sina, Amin, Neha P., Badiyan, Shahed N., Mohindra, Pranshu, Simone, Charles B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050808/ https://www.ncbi.nlm.nih.gov/pubmed/30014783 http://dx.doi.org/10.1177/1753466618783878 |
Ejemplares similares
-
Dramatic Response of a Large Sacral Chordoma to Intensity Modulated Proton Beam Therapy
por: Schneider, Craig, et al.
Publicado: (2017) -
Proton stereotactic body radiation therapy for non-small cell lung cancer
por: Diwanji, Tejan, et al.
Publicado: (2020) -
Surgery for early-stage small cell lung cancer: is it worth it?
por: Vyfhuis, Melissa A. L., et al.
Publicado: (2019) -
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer
por: Vyfhuis, Melissa A.L., et al.
Publicado: (2017) -
Excellent Pathologic Response and Atypical Clinical Course of High-Grade Extremity Sarcoma to Neoadjuvant Pencil Beam Scanning Proton Therapy
por: Remick, Jill, et al.
Publicado: (2017)